The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: A pilot study

Digestive Diseases and Sciences

Volumn 51, Issue 8, 2006, Pages 1501-1507

  Vejdani, Reyhaneh ^a,c   Shalmani, Hamid Reza Mohaghegh ^a   Mir Fattahi, Mina ^a   Sajed Nia, Faranak ^a   Abdollahi, Morteza ^a   Zali, Mohammad Reza ^a   Alizadeh, Amir Houshang Mohammad ^a   Bahari, Ali ^a   Amin, Gholamreza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

Carmint; Herbal medicine; Irritable bowel syndrome; Randomized placebo controlled trial

Indexed keywords

CARMINT; HERBACEOUS AGENT; ISPAGULA; LOPERAMIDE; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ANAL COMPLAINT; ANXIETY; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSURIA; FEMALE; FREQUENCY ANALYSIS; HEART PALPITATION; HERBAL MEDICINE; HUMAN; HYPERHIDROSIS; INTESTINE FUNCTION; IRRITABLE COLON; MALAISE; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STUDENT T TEST; SYMPTOM; THORAX PAIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT PREPARATIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748190277     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9079-3     Document Type: Article

References (28)

1. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45:43-47
2. Watson AR, Bowling TE (2005) Irritable bowel syndrome: diagnosis and symptom management. Br J Commun Nurs 10:118-122
3. Whitehead WE (1999) Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physical examination. Am J Med 107:33-40
4. Talley NJ, Zinsmeister AR, Melton J (1995) Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142:76-83
5. Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 128:580-589
6. Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, Guthrie E, Read N, Thompson D (2001) Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 134:860-868
7. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG (1993) US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 38:1569-1580
8. Heaton KW, O'Donnell LJD, Braddon FEM, Moutford RA, Hughes AO, Cripps PJ (1992) Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 102:1962-1967
9. Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG (1995) Comparison of bowel patterns in Hispanic and non-Hispanic whites. Dig Dis Sci 40:1761-1769
10. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroentroenterol Hepatol 7:427-433
11. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA (2000) (C) Functional bowel disorders and (D) functional abdominal pain. In: Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Rome II: The functional gastrointestinal disorders: Diagnosis, pathophysiology and treatment. A multinational consensus, 2nd ed. Degnon Associates, McLean, VA, pp 351-432
12. Jarrett M, Heitkemper MM, Bond EF, Georges J (1994) Comparison of diet composition in women with and without functional bowel disorder. Gastroenterol Nurs 6:253
13. Distrutti E, Azpiroz F, Soldevilla A, Malagelada JR (1999) Gastric wall tension determines perception of gastric distention. Gastroenterology 116:1035-1042
14. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR (1999) Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 116:573-585
15. Malcolm A, Phillips SF, Camilleri M, Hanson RB (1997) Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 92:2073-2079
16. Cann PA, Read NW, Holdsworth CD (1984) What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 25:168-173
17. Voderholzer WA, Schatke W, Muhldorfer BE, Klauser AG, Birkner B, Muller-Lissner SA (1997) Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 92:95-98
18. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC (1992) Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 67:725-731
19. Cann PA, Read NW, Holdsworth CD, Barends D (1984) Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci 29:239-247
20. Camilleri M (1999) Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 107(5A):27S-32S
21. Fleming T (2000) PDR for herbal medicines, 2nd ed. Medical Economics
22. Ballard C, O'Brien J, Reichelt K, Perry E (2002) Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 63:553-558
23. Sweetman SC (2005) Martindale, the complete drug reference, 34th ed. Pharmaceutical Press, p 1749
24. Drossman DA (2000) The functional gastrointestinal disorders, their diagnosis and the Rome II process. In: Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Rome II: The functional gastrointestinal disorders: Diagnosis, pathophysiology and treatment. A multinational consensus, 2nd ed. Degnon Associates, McLean, VA, pp 1-29
25. Quartero A, Meineche-Schmidt V, Muris J, Rubin G, de Wit N (2005) Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 18:CD003460
26. De Ponti R, Malagelada JR (1998) Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharm Ther 80(1):49-88
27. Dew MJ, Evans BK, Rhodes J (1984) Peppermint oil for the irritable bowel syndrome: A multicentre trial. Br J Clin Pract 38:394-398
28. Rees WDW, Evans BK, Rhodes J (1979) Treating the irritable bowel syndrome with peppermint oil. Br Med J 2:835-836